CD4+ Lymphocyte characteristics and HAART use of AIDS free women stratified by baseline CD4+ lymphocyte count
| Baseline CD4 <200 (n=224) | 200 ≤ Baseline CD4 <500 (n=573) | Baseline CD4 ≥500 (n=364) | ||||
|---|---|---|---|---|---|---|
| Time period | HAART use | Mean CD4 (cells/mm3) | HAART use | Mean CD4 (cells/mm3) | HAART use | Mean CD4 (cells/mm3) |
| *95% Confidence intervals in parentheses; †represents post 4/96 slope – pre 4/96 slope. | ||||||
| 10/94–3/95 | 1.4% | 112 | 0.0% | 344 | 0.0% | 733 |
| 4/95–9/95 | 0.5% | 116 | 0.6% | 361 | 0.0% | 703 |
| 10/95–3/96 | 2.0% | 96 | 0.9% | 352 | 0.0% | 696 |
| 4/96–9/96 | 16.8% | 125 | 5.9% | 358 | 3.0% | 664 |
| 10/96–3/97 | 52.9% | 151 | 23.4% | 372 | 11.1% | 684 |
| 4/97–9/97 | 61.7% | 173 | 39.1% | 369 | 19.0% | 595 |
| 10/97–3/98 | 62.3% | 188 | 46.8% | 358 | 23.8% | 618 |
| 4/98–9/98 | 63.1% | 211 | 46.7% | 370 | 28.7% | 607 |
| 10/98–3/99 | 66.0% | 231 | 56.0% | 383 | 35.7% | 592 |
| 4/99–9/99 | 73.9% | 223 | 59.7% | 388 | 35.0% | 586 |
| CD4+ slope per year 10/94–4/96* | 4.6 (−9.2 to 18.4) | 2.7 (−8.5 to 13.8) | −58.8 (−80.4 to −37.3) | |||
| CD4+ slope per year 4/96–9/99* | 35.6 (30.6 to 40.5) | 8.6 (5.0 to 12.3) | −27.8 (−34.6 to −21.0) | |||
| Difference of slopes*† | 31.0 (13.9 to 48.1) | 5.9 (−7.5 to 19.3) | 31.0 (5.2 to 56.8) | |||